Bio Green Med Solution (BGMS) Net Cash Flow (2010 - 2026)
Bio Green Med Solution (BGMS) posted quarterly Net Cash Flow of -$174000.0 for Q1 2026, down 143.61% year-over-year from $399000.0 in Q1 2025, and up 40.41% quarter-over-quarter from -$292000.0 in Q4 2025.
Powered by 
Analysis
Bio Green Med Solution (BGMS) Net Cash Flow (2010 - 2026) Analysis & Trends
Bio Green Med Solution (BGMS) has reported Net Cash Flow for 17 consecutive years, with -$174000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Net Cash Flow fell 143.61% year-over-year to -$174000.0; the TTM figure through Mar 2026 stood at -$79000.0 (down 109.96% YoY), while the FY2025 annual figure was $494000.0, up 394.05% from the prior year.
- Net Cash Flow climbed to -$174000.0 in Q1 2026 per BGMS's latest filing, from -$292000.0 in the prior quarter.
- Across five years, Net Cash Flow topped out at $3.2 million in Q2 2024 and bottomed at -$6.9 million in Q1 2023.
- Historically, Net Cash Flow has averaged -$1.9 million across 5 years, with a median of -$562000.0 in 2024.
- Annual changes were most pronounced in 2024 — Net Cash Flow jumped 336.36% — and 2025, when it tumbled 213.62%.
- Bio Green Med Solution's Net Cash Flow stood at -$5.1 million in 2022, then soared by 43.22% to -$2.9 million in 2023, then jumped by 108.83% to $257000.0 in 2024, then sank by 213.62% to -$292000.0 in 2025, then surged by 40.41% to -$174000.0 in 2026.
- Business Quant data shows BGMS's Net Cash Flow at -$174000.0 in Q1 2026, -$292000.0 in Q4 2025, and -$437000.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.61 Bn | 133.76 Bn | 2.84 Bn | 652.90 Mn |
| 2 | Regeneron Pharmaceuticals | 86.50 Bn | 78.50 Bn | 3.93 Bn | -504.30 Mn |
| 3 | Argenx Se | 64.82 Bn | 59.64 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.28 Bn | 52.14 Bn | 52.00 Mn | -183.00 Mn |
| 5 | Revolution Medicines | 44.45 Bn | 44.45 Bn | - | 374.50 Mn |
| 6 | BeOne Medicines | 40.32 Bn | 35.22 Bn | 1.53 Bn | 407.41 Mn |
| 7 | Alnylam Pharmaceuticals | 35.39 Bn | 32.08 Bn | 992.69 Mn | -496,000.00 |
| 8 | Royalty Pharma | 28.12 Bn | 27.29 Bn | - | 225.59 Mn |
| 9 | Insmed | 27.35 Bn | 26.19 Bn | 358.27 Mn | -37.14 Mn |
| 10 | Bio Green Med Solution | 4.95 Mn | 1.16 Mn | 79,000.00 | 421,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 421,000.00 |
| Mar 31, 2026 | -174,000.00 |
| Dec 31, 2025 | -292,000.00 |
| Sep 30, 2025 | -437,000.00 |
| Jun 30, 2025 | 824,000.00 |
| Mar 31, 2025 | 399,000.00 |
| Dec 31, 2024 | 257,000.00 |
| Sep 30, 2024 | -3.07 Mn |
| Jun 30, 2024 | 3.21 Mn |
| Mar 31, 2024 | -562,000.00 |
| Dec 31, 2023 | -2.91 Mn |
| Sep 30, 2023 | -4.09 Mn |
| Jun 30, 2023 | -1.36 Mn |
| Mar 31, 2023 | -6.92 Mn |
| Dec 31, 2022 | -5.13 Mn |
| Sep 30, 2022 | -5.44 Mn |
| Jun 30, 2022 | -444,000.00 |
| Mar 31, 2022 | -6.83 Mn |
| Dec 31, 2021 | -3.66 Mn |
| Sep 30, 2021 | -3.32 Mn |